维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Parker LM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ trial of the anti-VEGF antibody bevacizumab in combination with vinorelbine for refractory advanced breast cancer显示文摘	Berstein HJ Parker LM Savoie J	2002	Breast Cancer Res Treat2002，76，1：	1
2	Minimally invasive surgical techniques to treat spine infections显示文摘	Parker LM McAfee PC Fedder IL	1996	Orthop Clin North Am1996，27，1：	1
3	Oestrogen receptor downregulation:an opportunity for extending the window of endocrine therapy in advanced breast cancer显示文摘	Piccart M Parker LM Pritchard KI	2003	Ann Oncol2003，14，7：	1
4	VEGF as marker for outcome among advanced breast cancer patients receiving antiVEGF therapy with bevacizumab and vinorelbine chemotherapy显示文摘	Burstein HJ Chen YH Parker LM	2008	Clin Cancer res2008，14，23：	1
5	The mesothelial keratins a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinzing epithelia 显示文摘	Wu Y J Parker LM Binder NE	1982	Cell1982，31，：	1
6	Phase Ⅱ study of CT- 2103 as firstor second-line chemotherapy in patients with meta-static breast cancer: unexpected incidence of hypersensitivity reactions显示文摘	LIN NU PARKER LM COME SE	2007	Invest New Drugs2007，25，4：	1
7	Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy 显示文摘	Burstein HJ Parker LM Keshaviah A	2005	J Clin Oncol2005，23，33：	1
8	The use of hydrotalcite as an anion absorbent 显示文摘	Parker LM Milestone NB Newman RH	1995	Ind Eng Chem Res1995，34，4：	1
9	The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer:long-term result显示文摘	Griffiths CT Parker LM Lee S	2002	In J Gynecol Cancer2002，12，4：	1
10	An isolated depressed intraarticular fracture of the oleeranon:treatment with open reduction and internal fLxation显示文摘	Seiler JG 3rd Parker LM Eldridge JC	1995	J Hand Surg Am1995，20，1：	1
11	The bovine papillo- ma vires El protein has ATPase activity essential to viral DNA rep- lication and efficient transfonnation in cells 显示文摘	MacPhcrson P Thorner L Parker LM	1994	Virology1994，204，1：	1
12	MR imaging of anterior cruciate ligament tears:is there a gender gap?显示文摘	Fayad LM Parellada JA Parker L	2003	Skeletal Radiol2003，32，：	1
13	显示文摘	Tran CP Familari M Parker LM	1998	Am J Physiol1998，275，11：	1
14	Oestrogen receptor downregulation; an opportunity for extending the window of endocrine therapy in advanced breast cancer 显示文摘	Piccart M Parker LM Pritchard KI	2003	Ann Oncoi2003，14，7：	1
15	Phase II trial of the anti- VEGF antibody bevacizumab in combination with vinorelbine for refractory advanced breast cancer显示文摘	Burstein HJ Parker LM Savoie J	2002	Breast Cancer Res Treat2002，76，1：	1
16	Self-efficacy and self-rated oral health among pregnant aboriginal Australianwomen显示文摘	Jamieson LM Parker EJ Roberts-Thomson KF	2014	BMC Oral Health2014，2，14：	1
17	Phase Ⅱ trial of the anti-VEGF antibody bevacizumab in combination with vinorelbine for refractory advanced breast cancer 显示文摘	Burstein HJ Parker LM Savoie J	2002	Breast Cancer Res Treat2002，76，1：	1
18	Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer显示文摘	Piccart M Parker LM Pritchard KI	2003	Ann Oncol2003，14，7：	1
19	VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy显示文摘	Burstein HJ Chen YH Parker LM	2008	Clin Cancer Res2008，14，23：	1
20	Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine:a comparative endoscopic study using the Bagby and Kuslich interbody fusion device显示文摘	Cunningham BW Kanayama M Parker LM	1999	Spine1999，24，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示